Who is sponsoring NCT04330001?

NCT04330001 is sponsored by Alcon Research.

What drugs are being tested in NCT04330001?

Interventions in NCT04330001: Alcon Fluid Accommodating Intraocular Lens, Top Con Autorefractor.

What condition does NCT04330001 study?

NCT04330001 studies Aphakia, Presbyopia.

Is NCT04330001 still recruiting?

NCT04330001 is currently completed. Last updated 6 May 2023.

Last reviewed 2023-05-06 · How we verify

NCT04330001

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Exploratory Clinical Study for Techniques Associated With the Fluid Accommodating IOL

Completed NA Last updated 6 May 2023

What this trial tests

NA trial testing Alcon Fluid Accommodating Intraocular Lens in Aphakia in 99 participants. Completed in 3 May 2023.

Timeline

28 December 2020

Primary endpoint
8 June 2022

3 May 2023

Quick facts

Lead sponsor	Alcon Research
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	99
Start date	28 December 2020
Primary completion	8 June 2022
Estimated completion	3 May 2023
Sites	2 locations across El Salvador, Panama

Drugs / interventions tested

Alcon Fluid Accommodating Intraocular Lens
Top Con Autorefractor

Conditions studied

Aphakia — all drugs for Aphakia →
Presbyopia — all drugs for Presbyopia →

Sponsor

Alcon Research — full company profile →

Who can join

22 and older, any sex, with Aphakia or Presbyopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this clinical study is to assess the repeatability of objective refraction using auto refraction on subjects bilaterally implanted (implanted in both eyes) with the Fluid Accommodating IOL (FAIOL).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Aphakia

Currently open trials in the same condition.

NCT06258707 — Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL · NA · recruiting

Other Alcon Research trials

Trials by the same sponsor.

NCT06884202 — Evaluation of Delefilcon A Contact Lenses · NA · completed
NCT06784063 — Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs) · NA · completed
NCT06571656 — Evaluation of the Safety and Tolerability of Ocular Lubricants · NA · terminated
NCT06660290 — A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes · Phase 3 · completed
NCT06483113 — DAILIES TOTAL1® Soft Contact Lenses - Post-Market Clinical Follow-up Study · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04330001 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alcon Research
Last refreshed: 6 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04330001.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing